ArticleInternational journal of colorectal disease2025

Neoadjuvant triple-modality therapy with immune checkpoint blockade, anti-angiogenesis, and chemotherapy enhances pathologic response and survival in locally advanced and metastatic colorectal cancer: a multicenter cohort study.

Heng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.